47 results
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
13 Oct 23
Other Events
4:16pm
or comparable foreign regulatory authorities may conclude that a financial relationship between us and a principal investigator has created a conflict … of interest or otherwise affected interpretation of the study. The FDA or comparable foreign regulatory authorities may therefore question the integrity
8-K
EX-10.2
3nr68inn
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-4.1
ao2lw2y5je354 0h
17 Apr 23
Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
4:17pm
8-K
EX-1.1
8xezlu
10 Aug 22
Other Events
12:00am
8-K
EX-1.1
ketmo5d3cvi6pn eu5
15 Dec 20
Other Events
5:09pm